HappeningToo topic
Adalimumab-fkjp reports
Browse community reports connected to Adalimumab-fkjp. These reports can show that other people are describing similar experiences, but they do not prove that Adalimumab-fkjp caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
25 problems
Abdominal Discomfort while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and abdominal discomfort appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and abdominal pain upper appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and abdominal pain appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and alopecia appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and decreased appetite appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and diarrhea appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and dizziness appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Mouth while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and dry mouth appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and dyspepsia appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and fatigue appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and headache appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and hives appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and insomnia appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and itching appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and malaise appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and nausea appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and pain appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and rash appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and shortness of breath appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleep Disorder while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and sleep disorder appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Swelling while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and swelling appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and vomiting appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and weakness appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and weight decreased appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Adalimumab-fkjp
FDA FAERS contains adverse-event reports in which Adalimumab-fkjp and weight increased appear together. This does not establish that Adalimumab-fkjp caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →